Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSearch for a Mounjaro video and you will find dozens of clips showing the KwikPen being clicked against skin. Most are accurate about the physical steps. What they rarely cover is the clinical picture around those steps: who the medicine is for, what dose they are using, and why a prescriber made those choices. Mounjaro (tirzepatide) is a prescription-only medicine in the UK, available only after a clinician has assessed your health history, current BMI, and any weight-related conditions. A video can show you the mechanics of an injection. It cannot do the clinical work that decides whether the medicine is right for you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The standard Mounjaro UK video walks through the same sequence: remove the pen cap, choose an injection site, press the pen against the skin at a right angle, click the button, and hold for a count of ten. That ten-second hold is the part most people underestimate, releasing the pen early means not all the medicine has been delivered, and the video format is one of the clearest ways to show why the wait matters.
Good demonstrations also show the visual confirmation window changing colour, which signals a complete injection. They show the pen locking after use, so accidental re-injection is not possible. These mechanical details are genuinely useful, and watching a Mounjaro instructions video before your first dose is a sensible habit, not a replacement for reading the Patient Information Leaflet, but a useful companion to it.
One practical thing you can do in under a minute: after watching any demo, pause on the frame where the confirmation window appears and check that the colour the presenter describes matches the description in your own leaflet. If a video skips this step entirely, it is worth finding one that does not.
Technique is only part of the story. The Mounjaro tirzepatide licence covers adults with a BMI of 30 or above, or 27 and above with at least one weight-related condition such as high blood pressure, type 2 diabetes, or obstructive sleep apnoea. Videos are filmed by individuals sharing their own experience; their dose, their titration timing, and whether they have any of those conditions is not your information. Following their schedule (particularly if they post about moving up to 5 mg or 7.5 mg) is not a safe template for your own treatment.
The tirzepatide prescribing framework exists precisely because dose increases carry clinical judgement, not just a calendar. The most common side effects (nausea, loose stools, fatigue) typically peak after a dose change and settle within a couple of weeks, something a video posted on day two of a new dose will not capture, but which your prescriber should be factoring in. For a fuller picture of side effects and what to watch for, the NHS tirzepatide page covers the full profile with clear guidance on when to seek medical attention.
Not all injection-pen videos are the same device. Wegovy uses a different pre-filled pen with a different click mechanism and needle format. Saxenda (liraglutide) has its own pen entirely. If you search broadly for weight-loss injection tutorials, you may land on a video for a different medicine than the one you have been prescribed. The Mounjaro KwikPen is distinctive: it dispenses four doses per pen, each via a built-in, hidden needle that extends automatically on use. You never see the needle. That matters both practically and psychologically, many people find the first injection far less daunting than they expected.
If you want video content made specifically for the Mounjaro device, Eli Lilly's own Mounjaro video resources are the most authoritative source, as the manufacturer produced them against the approved SmPC. Separately, administration walk-throughs from clinical services tend to cover the storage and preparation steps that patient-created content skips: checking the pen for particles, allowing it to reach room temperature, and the rotation log for injection sites.
Once the physical steps are clear, the more important questions are clinical. What dose is appropriate given your weight, health history, and how you have responded so far? When should a dose increase happen, if at all? Are there any interactions with other medicines you take, common over-the-counter analgesics like ibuprofen, for instance, are worth discussing with your prescriber. And what is the cost structure of ongoing treatment? For a realistic picture of what private Mounjaro treatment involves financially, the cost breakdown on our Mounjaro page sets out what a legitimate private price should include.
It is also worth knowing that the injection technique question and the clinical question are both handled at assessment. Every consultation at nume is reviewed by a GPhC-registered Independent Prescriber on the day it is submitted. There are no algorithms making the call. If you have watched the demos, done the reading, and want to know whether Mounjaro is clinically suitable for you, the consultation is free to start.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.